ArticleBMC microbiology2026
Oral dryness related symptoms in radiation-treated head and neck cancer patients: a pilot study of oral microbiome composition and function.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02057510 (Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionXerostomia (dry mouth) and dysgeusia (taste changes) are subjective oral symptoms affecting radiation-treated head and neck cancer (HNC) patients. Our objective was to determine longitudinal and cross-sectional changes in oral microbiome profiles and predicted molecular pathways.
methodsSaliva and tongue swab samples from HNC patients (N = 25) were collected at baseline (BL) and 18-months (18mos) post-radiation therapy (RT). 16S-rRNA gene V1-V3 next generation sequencing was performed. Subjective xerostomia and dysgeusia scores were determined using EORTC QLQ-H&N ranking scale. Patient groups were classified by worsening symptom severity (high > 2.5 vs low < 2.5) at BL and 18mos. For xerostomia, longitudinal comparisons included high vs low scores at BL and 18mos (N = 26, N = 52; N = 24, N = 48), cross-sectional comparisons included BL high vs low (N = 2 vs 23; N = 4 vs 46) and 18mos high vs low (N = 15 vs 10; N = 30 vs 20). For dysgeusia, longitudinal comparisons included high vs low scores at BL and 18mos (N = 16; N = 32; N = 34, N = 68), and cross-sectional comparisons included BL high vs low (N = 2 vs 23; N = 4 vs 46) and 18mos high vs low (N = 12 vs 13; N = 24 vs 26). α-diversity significance was determined via Mann–Whitney U-test and β-diversity was determined via PERMANOVA. PiCrust2 was used to predict bacterial pathways alterations. MaAsLin2 program was used to determine microbial and pathway associations between timepoint and scoring. ROC curve analysis was used to identify candidate taxa biomarkers.
resultsα-diversity did not differ among comparisons. Longitudinal β-diversity comparisons were all significant (p < 0.05). All, but one cross-sectional comparison, were not significant. MaAsLin2 determined 32 significant taxonomic and 14 MetaCyc pathway features. Haemophilus parainfluenzae (padj = 0.01) and Gemella sanguinis (padj = 0.006) were significant taxa distinguishing high and low score dysgeusia groups, per multivariate analysis. Streptococcus salivarius and Ralstonia pickettii were consistently most abundant contributors to pathway alterations. Significant pathways included PWY-7431 (Timepoint; p = 0.001) and KDO-NAGLIPASYN-PWY (BL dysgeusia; p = 0.00035).
conclusionsOral microbial composition and functional changes occur post-RT that may contribute to xerostomia and dysgeusia. Significant species H. parainfluenzae, G. sanguinis, S. salivarius, and R. pickettii may be involved in xerostomia and taste change post-RT and may be further investigated for possible characterization as biomarkers at the functional level for dry mouth and taste change.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.